Rapid Aneurysm is an FDA-approved imaging platform for cerebral aneurysm management, helping physicians save time, mitigate risk, improve patient care and increase revenue by automating the process of finding, tracking and proactively treating aneurysms.
From a patient’s imaging scans, the platform creates a personalized 3D model of the vasculature, highlighting potential aneurysms, and provides tools for accurate measurement and identification of morphological changes.
of cases, physicians selected a device size that was different from the original conventionally planned device size
increase in physician confidence regarding device selection
average absolute difference between clinical and simulated flow-diverter lengths
Virtual Pipeline Flex deployment in SurgicalPreview® during pre-treatment planning showing physician device selection
Pre-treatment rotational angiography
Post-treatment rotational angiography
Post-treatment rotational angiography showing deployment of the selected device
Virtual Pipeline Flex deployment in SurgicalPreview® during pre-treatment planning showing physician device selection
Post-treatment rotational angiography showing deployment of the selected device
Virtual Pipeline Flex deployment in SurgicalPreview® during pre-treatment planning showing physician device selection
Pre-treatment rotational angiography
Post-treatment rotational angiography showing deployment of the selected device
Virtual Pipeline Flex deployment in SurgicalPreview® during pre-treatment planning showing physician device selection
Pre-treatment rotational angiography
Post-treatment rotational angiography showing deployment of the selected device
Virtual Pipeline Flex deployment in SurgicalPreview® during pre-treatment planning showing physician device selection
Post-treatment rotational angiography showing deployment of the selected device
Our simulation services revolutionize the way endovascular devices are designed and developed. Our computational models provide far more detail than physical testing and dramatically reduce development time.
We also test devices in hundreds of patient anatomies without the patients, creating a “virtual clinical trial.” Our reports comply with all regulatory requirements and are ready for filing. If reducing the cost and time to market is important, put our computational services to work for you.